Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Miroslav Merta"'
Autor:
Veronika Elisakova, Miroslav Merta, Jana Reiterova, Alica Baxova, Jaroslav Kotlas, Katerina Hirschfeldova, Lena Obeidova, Vladimir Tesar, Jitka Stekrova
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-7 (2018)
Abstract Background Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary renal disorder, leading to end stage renal failure and kidney transplantation in its most serious form. The severity of the disease’s manifestati
Externí odkaz:
https://doaj.org/article/a4bd93f497214e91a08c006bd6bb99c3
Autor:
Miroslav Merta
Publikováno v:
Gastroenterologie a hepatologie. 75:445-450
Summary: The treatment of gastrointestinal tract (GIT) diseases may, under specific conditions, be significantly influenced by the kidneys or by kidney disorders. One of the potential scenarios of such interaction is the concurrent involvement of the
Autor:
Dita Maixnerova, Michaela Neprasova, Jelena Skibova, Jana Mokrisova, Romana Rysava, Jana Reiterova, Eva Jancova, Miroslav Merta, Josef Zadrazil, Eva Honsova, Vladimir Tesar
Publikováno v:
Kidney & Blood Pressure Research, Vol 39, Iss 6, Pp 555-562 (2014)
Background/Aims: The aim of our study was to retrospectively analyse data of 520 Czech patients with IgA nephropathy (IgAN) and to specify the risk factors affecting renal survival of IgAN patients. Methods: Cox proportional hazards regression model
Externí odkaz:
https://doaj.org/article/1d7a19a972a24a1a84f941db31658807
Autor:
Miroslav Merta
Publikováno v:
Gastroenterologie a hepatologie. 73:250-256
K soucasnemu postiženi jater a ledvin dochazi poměrně casto a toto dualni postiženi může mit různou podobu. Nove poznatky naznacuji, že při postiženi jater a ledvin se mohou uplatňovat některe spolecne patogeneticke mechanizmy a spise ne
Autor:
Roman Safranek, Michaela Kubisova, Lydia Habanova, Petr Moucka, Jakub Visek, Marta Kalousova, Miroslav Merta, Lubos Sobotka, Sylvie Dusilova Sulkova
Publikováno v:
Kidney Research and Clinical Practice, Vol 31, Iss 2, p A70 (2012)
Fetuin-A is a calcification inhibitor, negative acute phase response marker and cardiovascular mortality predictor in hemodialysis patients. Low levels of fetuin-A are associated with malnutrition, inflammation, decreased bone mass density, low-turno
Externí odkaz:
https://doaj.org/article/82d7e11f61df467c8eccf1c0b4581c6d
Autor:
Miroslav Merta
Publikováno v:
Gastroenterologie a hepatologie. 72:441-448
Autor:
Vladimir Tesar, Michaela Neprasova, Eva Jancova, Jana Mokrisova, Josef Zadrazil, Jelena Skibova, Miroslav Merta, Romana Rysava, Dita Maixnerova, Eva Honsova, Jana Reiterova
Publikováno v:
Kidney & Blood Pressure Research, Vol 39, Iss 6, Pp 555-562 (2014)
Background/Aims: The aim of our study was to retrospectively analyse data of 520 Czech patients with IgA nephropathy (IgAN) and to specify the risk factors affecting renal survival of IgAN patients. Methods: Cox proportional hazards regression model
Autor:
Eva Honsova, Romana Rysava, Jelena Skibova, Miroslav Merta, Dita Maixnerova, Lenka Bauerová, Vladimir Tesar, Jana Reiterova
Publikováno v:
Nephrology Dialysis Transplantation. 27:1492-1498
The aim of our study was to retrospectively analyse the clinical data and the histological findings of 343 patients (pts) followed up with IgA nephropathy (IgAN) in our department of nephrology. We have assessed the main demographic, clinical and his
Autor:
Jakub Zavada, Eva Jancova, Miroslav Merta, Tomas Loster, Vladimir Tesar, Zdenka Hruskova, Helena Mareckova, Zuzana Rihova, Romana Rysava
Publikováno v:
Archives of Medical Research. 40:276-284
Dysregulation of cell-mediated immune response likely plays a role in the pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV), but it has not yet been fully established. The aim of this study was to assess the
Autor:
Ctibor Dostál, Zdenka Vankova, Eva Jancova, Romana Rysava, Vladimir Tesar, Miroslav Merta, Eva Honsova, Zuzana Rihova, Dita Maixnerova
Publikováno v:
Kidney and Blood Pressure Research. 30:124-128
Background: The optimal therapy for lupus nephritis (LN), including the role of cyclosporine (CsA), still lacks scientifically valid clinical experience. We evaluated the efficacy of CsA in the induction and maintenance treatment of patients with bio